GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Median Diagnostics Inc (XKRX:233250) » Definitions » Additional Paid-In Capital

Median Diagnostics (XKRX:233250) Additional Paid-In Capital : ₩6,823 Mil(As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Median Diagnostics Additional Paid-In Capital?


Median Diagnostics's quarterly additional paid-in capital increased from Dec. 2022 (₩6,811 Mil) to Dec. 2023 (₩6,823 Mil) but then stayed the same from Dec. 2023 (₩6,823 Mil) to Dec. 2024 (₩6,823 Mil).

Median Diagnostics's annual additional paid-in capital increased from Dec. 2022 (₩6,811 Mil) to Dec. 2023 (₩6,823 Mil) but then stayed the same from Dec. 2023 (₩6,823 Mil) to Dec. 2024 (₩6,823 Mil).

Median Diagnostics Additional Paid-In Capital Historical Data

The historical data trend for Median Diagnostics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Diagnostics Additional Paid-In Capital Chart

Median Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,774.65 6,774.65 6,811.38 6,822.80 6,822.80

Median Diagnostics Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,774.65 6,774.65 6,811.38 6,822.80 6,822.80

Median Diagnostics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Median Diagnostics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Median Diagnostics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Median Diagnostics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Median Diagnostics Inc (XKRX:233250) » Definitions » Additional Paid-In Capital
Comparable Companies
XKRX:336040 XKRX:900120 XKRX:318010 XKRX:018620 XKRX:354390 XKRX:034940 XKRX:018680 XKRX:053950 XKRX:200230 XKRX:314140 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
878 Seoul Office, Dongnae-dong, Kangwon-do, Chuncheon, KOR, 200-883
Website
http://www.mediandiagnostics.com
Median Diagnostics Inc is a Korea based company engaged in providing IVD solutions and veterinary diagnostics services. Its solutions portfolio covers avian influenza diagnosis solution, foot and mouth disease diagnosis solution, African Pig fever solution and others. The company offers ELISA diagnostic products, rapid test kit, molecular diagnosis products, standard diagnosis products and biologicals.

Median Diagnostics Headlines

No Headlines